A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/20 (2006.01) A61K 9/48 (2006.01)
Patent
CA 2550983
Disclosed are products and methods for improving the plasma profile in a patient being treated with a pharmaceutical active agent that is subject to a limited window of absorption, which products and methods comprise orally administering the active agent in multiparticulate form, such that at least a portion thereof is delivered to the intestine while the patient is in the fed condition.
L'invention concerne des produits et des méthodes destinés à améliorer le profil plasmatique chez un patient traité avec un agent actif d'un point de vue pharmaceutique soumis à un degré limité d'absorption, lesdits produits et méthodes étant associés à l'administration orale de l'agent actif sous forme multiparticulaire, de manière qu'au moins une partie de celui-ci soit délivrée à l'intestin tandis que le patient est alimenté.
Burnside Beth A.
Flanner Henry H.
Guttendorf Robert J.
Treacy Donald J. Jr.
Advancis Pharmaceutical Corporation
Shionogi Inc.
Smart & Biggar
LandOfFree
Enhanced absorption of modified release dosage forms does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced absorption of modified release dosage forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced absorption of modified release dosage forms will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1845853